Critically, midazolam treatment ameliorated hyperglycemia-induced glomerular microvascular endothelial dysfunction by inhibiting intracellular Ca2+ elevation and subsequent ROS generation and TGase 2 activation. This evidence concerns the gene TGM2 and Hyperglycemia.